Table 1.
Number of children with an adverse outcome according to congenital infection status (%)
| 1) DEVELOPMENT AND BEHAVIOUR | |||||
| PARENT COMPLETED | |||||
| Infection status | Motor1 | Speech & language1 | Behaviour2 | Cognition1 | |
| CT+ (n = 178) | 24/178 (13.5) | 20/177 (11.3) | 34/176 (19.3) | 9/178 (5.1) | |
| CT- (n = 527) | 58/525 (11.0) | 50/524 (9.5) | 97/527 (18.4) | 31/525 (5.9) | |
| CHILD COMPLETED | |||||
| Infection status | 'Draw a Man'1 | Line, circle, cross1 | |||
| CT+ (n = 178) | 17/121(14.0) | 13/170(7.6) | |||
| CT- (n = 527) | 54/372(14.5) | 38/500(7.4) | |||
| 2) PARENTAL CONCERNS, SPECIALIST REFERRAL, AND PARENTAL ANXIETY | |||||
| CONCERNS | |||||
| Learning/ development3 | Speech & language3 | ANY3 | |||
| CT+ (n = 178) | 24/176(13.6) | 16/177(9.0) | 34/178(19.1) | ||
| CT- (n = 527) | 53/522(10.2) | 55/522(10.5) | 79/527(15.0) | ||
| REFERRALS | |||||
| Learning/ development | Speech & language | ANY | Behaviour impact 2 | Parental anxiety1 | |
| CT+ (n = 178) | 10/178(5.6) | 4/178(2.3) | 11/178(6.2) | 3/173 (1.7) | 41/176 (23.3) |
| CT- (n = 527) | 13/527(2.5) | 14/527(2.7) | 20/527(3.8) | 16/509 (3.1) | 61/521 (11.7) |
| 3) PARENT-REPORTED IMPAIRMENT | |||||
| VISUAL IMPAIRMENT | |||||
| Glasses only | Strabismus/ blind/limited vision | ANY | Hearing loss4 | Neurological/mobility impairment5 | |
| CT+ (n = 178) | 5 | 10 | 15/177 (8.5) | 7/166 (4.2) | 2/175 (1.1) |
| CT- (n = 527) | 11 | 13 | 24/527 (4.6) | 30/498(6.0) | 4/522 (0.8) |
Full questionnaire available from the EMSCOT website [22]
CT = congenital toxoplasmosis
1Adverse outcome defined by score corresponding most closely to the least able/most worried 10% in the uninfected children
2Adverse outcome defined by developers of SDQ questionnaire. Equivalent to lowest 10% in community sample of 10,000 examined in evaluation study. [12]
3Defined by answering 'yes' or 'a little' to question(s) about concerns.
4Parents reported intermittent or permanent hearing loss
5Parents reported seizures requiring treatment, cerebral palsy, and/or impaired mobility